Elanco Animal Health (ELAN)
NYSE: ELAN
· Real-Time Price · USD
17.95
-0.05 (-0.28%)
At close: Aug 15, 2025, 3:59 PM
17.96
0.08%
After-hours: Aug 15, 2025, 06:16 PM EDT
Elanco Animal Health Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 434M | 373M | 338M | 205M | -1.25B | -1.3B | -1.23B | -1.15B | -98M | -23M | -78M | -120M | -175M | -363M | -472M | -697.8M | -728.8M | -572M |
Depreciation & Amortization | 664M | 657M | 662M | 669M | 672M | 687M | 694M | 691M | 685M | 679M | 682M | 688M | 691M | 690M | 716M | 764.2M | 726.5M | 637.4M |
Stock-Based Compensation | 65M | 59M | 55M | 55M | 50M | 45M | 46M | 46M | 49M | 57M | 59M | 62M | 66M | 65M | 66M | 64.6M | 59.3M | 51.6M |
Other Working Capital | 211M | -4M | 56M | 146M | 18M | -38M | -300M | -171M | -213M | -217M | -109M | -110M | -148M | -117M | 31M | -657.5M | -519.3M | -296.8M |
Other Non-Cash Items | -802M | -550M | -570M | -501M | 78M | 35M | 69M | 34M | 66M | 270M | 308M | 331M | 326M | 375M | 414M | 488.3M | 299.8M | -1.1M |
Deferred Income Tax | n/a | n/a | n/a | -53M | 994M | 991M | 993M | 1.02B | -18M | -44M | -57M | -71M | -80M | -133M | -154M | -84M | -160.4M | -131.7M |
Change in Working Capital | 211M | -4M | 56M | 146M | 18M | -38M | -300M | -524M | -566M | -570M | -462M | -228M | -266M | -235M | -87M | -368.2M | -230M | -7.5M |
Operating Cash Flow | 572M | 535M | 541M | 521M | 557M | 418M | 271M | 127M | 118M | 369M | 452M | 662M | 562M | 399M | 483M | 167.1M | -33.6M | -23.3M |
Capital Expenditures | -217M | -194M | -153M | -141M | -132M | -140M | -154M | -192M | -205M | -196M | -184M | -196M | -175M | -167M | -197M | -252.9M | -332.3M | -322.5M |
Cash Acquisitions | -31M | -24M | -36M | n/a | -8M | -8M | -19M | -17M | -3M | -3M | 13M | 11M | -415M | -415M | -342M | -5.34B | -9.49B | -9.49B |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.05B | 5.05B | 5.05B |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 7.5M |
Other Investing Acitivies | 1.28B | 1.27B | 1.34B | 1.35B | 73M | 71M | 4M | -1M | -3M | -6M | -8M | -17M | -16M | -20M | -24M | 13.4M | -12.1M | 14.2M |
Investing Cash Flow | 1.04B | 1.06B | 1.16B | 1.21B | -67M | -77M | -169M | -210M | -211M | -205M | -179M | -177M | -581M | -569M | -530M | -529.3M | -4.79B | -4.75B |
Debt Repayment | -1.3B | -1.39B | -1.48B | -1.58B | -400M | -271M | -77M | -8M | -6M | -132M | -502M | -386M | n/a | 22M | 241M | 177.7M | 4.11B | 4.18B |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 144M | -23M | -17M | -23M | -16M | -13M | -6M | -20M | -34M | -43M | -47M | -35M | -21M | -14M | -31M | -30M | -129.7M | -115.9M |
Financial Cash Flow | -1.48B | -1.41B | -1.49B | -1.6B | -416M | -284M | -83M | -28M | -40M | -175M | -549M | -421M | -21M | 8M | 210M | 147.7M | 3.98B | 4.06B |
Net Cash Flow | 123M | 142M | 116M | 121M | 49M | 27M | 7M | -91M | -140M | -24M | -293M | 7M | -73M | -173M | 132M | -218.2M | -822.4M | -702.7M |
Free Cash Flow | 355M | 341M | 388M | 380M | 425M | 278M | 117M | -65M | -87M | 173M | 268M | 466M | 387M | 232M | 286M | -85.8M | -365.9M | -345.8M |